164 related articles for article (PubMed ID: 19795349)
21. Immunohistochemical localization of the glucose transporter GLUT1 in choroid plexus papillomas.
Kurosaki M; Hori T; Takata K; Kawakami H; Hirano H
Noshuyo Byori; 1995 Mar; 12(1):69-73. PubMed ID: 7795732
[TBL] [Abstract][Full Text] [Related]
22. Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasms.
Schittenhelm J; Psaras T; Meyermann R; Honegger J; Beschorner R
Folia Neuropathol; 2010; 48(2):75-80. PubMed ID: 20602288
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of CDX2 in colorectal cancers.
Choi BJ; Kim CJ; Cho YG; Song JH; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
APMIS; 2006 Jan; 114(1):50-4. PubMed ID: 16499661
[TBL] [Abstract][Full Text] [Related]
24. Choroid plexus epithelium (normal and neoplastic) expresses synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas.
Kepes JJ; Collins J
J Neuropathol Exp Neurol; 1999 Apr; 58(4):398-401. PubMed ID: 10218635
[TBL] [Abstract][Full Text] [Related]
25. Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas.
Sen A; Mitra S; Das RN; Dasgupta S; Saha K; Chatterjee U; Mukherjee K; Datta C; Chattopadhyay BK
Indian J Pathol Microbiol; 2015; 58(2):158-62. PubMed ID: 25885126
[TBL] [Abstract][Full Text] [Related]
26. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.
Altura RA; Olshefski RS; Jiang Y; Boué DR
Br J Cancer; 2003 Nov; 89(9):1743-9. PubMed ID: 14583779
[TBL] [Abstract][Full Text] [Related]
27. High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors.
Japp AS; Gessi M; Messing-Jünger M; Denkhaus D; Zur Mühlen A; Wolff JE; Hartung S; Kordes U; Klein-Hitpass L; Pietsch T
J Neuropathol Exp Neurol; 2015 Feb; 74(2):110-20. PubMed ID: 25575132
[TBL] [Abstract][Full Text] [Related]
28. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.
La Rosa S; Rigoli E; Uccella S; Chiaravalli AM; Capella C
Virchows Arch; 2004 Sep; 445(3):248-54. PubMed ID: 15517368
[TBL] [Abstract][Full Text] [Related]
29. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus.
Megerian CA; Pilch BZ; Bhan AK; McKenna MJ
Laryngoscope; 1997 Feb; 107(2):216-21. PubMed ID: 9023246
[TBL] [Abstract][Full Text] [Related]
31. Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma.
Bakaris S; Cetinkaya A; Ezberci F; Ekerbicer H
Histol Histopathol; 2008 Sep; 23(9):1043-7. PubMed ID: 18581275
[TBL] [Abstract][Full Text] [Related]
32. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
[TBL] [Abstract][Full Text] [Related]
33. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
Werling RW; Yaziji H; Bacchi CE; Gown AM
Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
[TBL] [Abstract][Full Text] [Related]
34. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2.
Modica S; Morgano A; Salvatore L; Petruzzelli M; Vanier MT; Valanzano R; Esposito DL; Palasciano G; Duluc I; Freund JN; Mariani-Costantini R; Moschetta A
Gut; 2009 Sep; 58(9):1250-9. PubMed ID: 19221108
[TBL] [Abstract][Full Text] [Related]
35. Loss of TP53 expression in immortalized choroid plexus epithelial cells results in increased resistance to anticancer agents.
Krzyzankova M; Mertsch S; Koos B; Jeibmann A; Kruse A; Kordes U; Frühwald MC; Wolff JE; Paulus W; Hasselblatt M
J Neurooncol; 2012 Sep; 109(3):449-55. PubMed ID: 22763759
[TBL] [Abstract][Full Text] [Related]
36. The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas.
Gottschalk J; Jautzke G; Paulus W; Goebel S; Cervos-Navarro J
Cancer; 1993 Aug; 72(4):1343-9. PubMed ID: 7687923
[TBL] [Abstract][Full Text] [Related]
37. Aquaporin(s) expression in choroid plexus tumours.
Longatti P; Basaldella L; Orvieto E; Dei Tos A; Martinuzzi A
Pediatr Neurosurg; 2006; 42(4):228-33. PubMed ID: 16714863
[TBL] [Abstract][Full Text] [Related]
38. Tumors of the choroid plexus.
Rickert CH; Paulus W
Microsc Res Tech; 2001 Jan; 52(1):104-11. PubMed ID: 11135453
[TBL] [Abstract][Full Text] [Related]
39. MIB-1 immunoreactivity reveals different labelling in low-grade and in malignant epithelial neoplasms of the choroid plexus.
Vajtai I; Varga Z; Aguzzi A
Histopathology; 1996 Aug; 29(2):147-51. PubMed ID: 8872148
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases.
Paulus W; Jänisch W
Acta Neuropathol; 1990; 80(6):635-41. PubMed ID: 1703384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
